A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
To evaluate the efficacy and safety of B001 injection in aquaporin-4 antibody positive patients with neuromyelitis optica spectrum disorder.
Epistemonikos ID: 62e1f3dcec42f60e15ef8149425b510061b9cb1f
First added on: May 22, 2024